Technology News and Research

RSS

Precision Antibody to develop antibodies for NCI's Clinical Proteomic Technologies for Cancer

Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.

28 Oct 2009

HealthEdge launches Benefit Predictor enterprise-class software platform

HealthEdge, provider of the only modern, enterprise-class software platform for healthcare payors, today announced the availability of Benefit Predictor, a revolutionary new capability that is now a standard part of its HealthRules Payor application. This new functionality provides HealthEdge clients with a significant competitive advantage related to both transparency and customer service, as it enables them to quickly and easily answer the most complex benefit questions from their members and providers.

28 Oct 2009

Global Rainmakers to commercialize its suite of cutting-edge biometric technologies

Global Rainmakers, Inc., an intellectual property holding company and advanced R&D laboratory, today announced that the company has exited its "stealth" mode and is prepared to actively commercialize its suite of technologies designed to leverage cutting-edge biometric security offerings.

28 Oct 2009

U.S. PTO awards Endocyte patent for vitamin receptor binding anti-cancer agents

Officials at Endocyte Inc., a cancer drug discovery and development company, announced Tuesday (Oct. 27, 2009) that the company has been awarded a patent from the U.S. Patent and Trademark Office covering vitamin receptor binding anti-cancer agents.

28 Oct 2009

Ohio State University researchers first to observe real-time behavior of the Dpo4 enzyme

Scientists here have identified how the motions of an enzyme are related to correctly copying genetic instructions, setting the stage for studies that can uncover what happens when DNA copying mistakes are made.

28 Oct 2009

Microbix and Hunan Biopharmaceutical to build $200-million influenza vaccine facility

Microbix, a developer of a patented technology that doubles the output of influenza vaccine production, announced today it has signed a joint venture agreement with the Hunan Biopharmaceutical Co. Ltd. (a Hunan Province state-owned enterprise) for initial financing to construct Asia's largest influenza vaccine production facility and the third largest vaccine plant in the world.

28 Oct 2009

The Endocrine Society urges NIH to increase funding for stem cell research

Stem cell research holds great promise for the treatment of millions of Americans with debilitating and possibly fatal diseases. Current legislation and guidelines, however, continue to limit researchers' endeavors in unlocking the potential breakthroughs that stem cell research can provide. To address this concern, today The Endocrine Society issued a Position Statement (http://www.endo-society.org/advocacy/policy) calling for an increase in NIH funding for stem cell research as well as expanding the scope of funding to include promising yet neglected areas of stem cell research.

28 Oct 2009

Biomagnetics Diagnostics completes negotiations to acquire IBOS technology

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis, and malaria detection, today announced the Company has completed business negotiations with one of the U.S. Government's top national security research institutions regarding the acquisition of rights to the Integrated Optical Biosensor System (IBOS) technology developed by the laboratory personnel. Biomagnetics Diagnostics plans to utilize this technology to enter the significantly underserved market for handheld biosensors capable of detecting a broad range of disease-causing viruses, bacteria and fungi.

28 Oct 2009

Breakthrough ophthalmic laser delivery technology introduced at the AAO Annual Meeting

Lumenis Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it introduced a breakthrough ophthalmic laser delivery technology on October 24th at the American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, California, USA.

28 Oct 2009

VHA helps nurses to develop work processes that are more patient-centric

Nurses work in a world of broken systems, wasted time and energy, which can be incredibly frustrating and detrimental to patient care. Most national studies show that nurses spend as little as 30 percent of their day engaged in direct patient care activities, and this can contribute to poor patient outcomes in terms of infections and other complications, poor patient and nurse satisfaction and poor quality of care overall.

28 Oct 2009

Manhattan Scientifics and Senior Scientific team up to commercialize cancer detection technology

Manhattan Scientifics (OTCBB: MHTX) and Senior Scientific, LLC announced today that they have begun cooperative work to commercialize Senior Scientific’s nano medicine cancer detection technology.

28 Oct 2009

Experts release policy recommendations to promote better medication adherence and health outcomes

A diverse group of health care and consumer organizations released five policy recommendations this week that are designed to promote better medication adherence and improved health outcomes for patients.

28 Oct 2009

D3 FastPoint L-DFA Influenza A/ Influenza B Virus Identification Kit receives FDA clearance

Diagnostic Hybrids, a leading developer of in vitro diagnostic fluorescent staining kits and cell culture products, announces the U.S. Food and Drug Administration (FDA) (510k) clearance of its D3 FastPointTM L-DFATM Influenza A/ Influenza B Virus Identification Kit, which allows for the identification of influenza A virus and influenza B virus from a patient’s specimen in under 30 minutes.

28 Oct 2009

New integrated technology system to be implemented in Jordan's healthcare system

The Hashemite Kingdom of Jordan, in a public demonstration today hosted by His Majesty King Abdullah II, provided a stunning look at the new integrated healthcare technology system being implemented for the people of Jordan in the coming year.

28 Oct 2009

Nasopharyngeal Flocked Swabs are recommended for H1N1 and influenza A testing

Preparing for this flu season, the American Society for Microbiology (ASM) PSAB Committee on Laboratory Practices has recently published a new interim algorithm providing guidance to clinical laboratories responsible for testing patients with respiratory illness for Influenza A, including H1N1.

28 Oct 2009

NCI funds pilot study to measure human proteins

An expert in cancer proteomics at Fred Hutchinson Cancer Research Center has received $4.8 million in federal stimulus funding from the National Cancer Institute to co-lead a pilot study to assess the feasibility and scalability of a project that aims to measure all of the proteins in the human body.

28 Oct 2009

NCI grant to conduct innovative cancer research

A consortium led by The University of Texas Health Science Center at Houston has been awarded a major grant from the National Cancer Institute (NCI) to establish a center to conduct innovative cancer research.

28 Oct 2009

National Heart, Lung and Blood Institutes funds multi-year project

Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) will receive $10 million over the next 6 years to find the genetic causes of congenital heart disease.

28 Oct 2009

St. Jude Children's Research Hospital named among the top 10 "Best Places to Work in Academia"

St. Jude Children's Research Hospital has been listed among the top 10 "Best Places to Work in Academia" by The Scientist magazine -- this year's seventh place ranking is the fourth straight year the institution has placed in the top 10.

27 Oct 2009

Medicines used for lowering blood cholesterol may be effective in the treatment of cancer

Millions of people around the world use medicines based on statins to lower their blood cholesterol, but new research from the University of Gothenburg, published in the prestigious journal PNAS, shows that statins may also be effective in the treatment of cancer.

27 Oct 2009

Technology News and Research

Precision Antibody to develop antibodies for NCI's Clinical Proteomic Technologies for Cancer

HealthEdge launches Benefit Predictor enterprise-class software platform

Global Rainmakers to commercialize its suite of cutting-edge biometric technologies

U.S. PTO awards Endocyte patent for vitamin receptor binding anti-cancer agents

Ohio State University researchers first to observe real-time behavior of the Dpo4 enzyme

Microbix and Hunan Biopharmaceutical to build $200-million influenza vaccine facility

The Endocrine Society urges NIH to increase funding for stem cell research

Biomagnetics Diagnostics completes negotiations to acquire IBOS technology

Breakthrough ophthalmic laser delivery technology introduced at the AAO Annual Meeting

VHA helps nurses to develop work processes that are more patient-centric

Manhattan Scientifics and Senior Scientific team up to commercialize cancer detection technology

Experts release policy recommendations to promote better medication adherence and health outcomes

D3 FastPoint L-DFA Influenza A/ Influenza B Virus Identification Kit receives FDA clearance

New integrated technology system to be implemented in Jordan's healthcare system

Nasopharyngeal Flocked Swabs are recommended for H1N1 and influenza A testing

NCI funds pilot study to measure human proteins

NCI grant to conduct innovative cancer research

National Heart, Lung and Blood Institutes funds multi-year project

St. Jude Children's Research Hospital named among the top 10 "Best Places to Work in Academia"

Medicines used for lowering blood cholesterol may be effective in the treatment of cancer

Industry Focus eBook - Cell biology (5th edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News